World Daily News

Wegovy: New Anti-Obesity Drug Launches in France with Strict Access Conditions

Wegovy, a new anti-obesity drug from Novo Nordisk, is now available in France, but access is restricted to patients meeting specific criteria set by health authorities. The drug's high cost and lack of insurance coverage raise concerns about equitable access for those affected by obesity.

Life

UK Government Trials Weight-Loss Injections to Combat Obesity and Unemployment

2024-10-16T05:41:50.572Z

The UK government is initiating a trial of weight-loss injections to assist unemployed individuals with obesity, aiming to alleviate the burden on the NHS and improve economic participation.

2024/10/16

Life

UK Government Trials Weight-Loss Injections to Combat Obesity and Unemployment

2024-10-16T05:41:50.572Z

The UK government is initiating a trial of weight-loss injections to assist unemployed individuals with obesity, aiming to alleviate the burden on the NHS and improve economic participation.